Cargando…
Myocardial infarction risk and tamoxifen therapy for breast cancer
Tamoxifen prevents recurrence after breast cancer and breast cancer among high-risk women, and may prevent myocardial infarction (MI). To assess the impact of tamoxifen on MI risk, we conducted a case–control study of first MI after breast cancer nested among women diagnosed with breast cancer, whil...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362055/ https://www.ncbi.nlm.nih.gov/pubmed/15841078 http://dx.doi.org/10.1038/sj.bjc.6602562 |